Biology of Blood and Marrow Transplantation volume 22, issue 6, P1037-1042 2016 DOI: 10.1016/j.bbmt.2016.03.004 View Full Text
|
|
Share
Ivan S. Moiseev, Olga V. Pirogova, Alexandr L. Alyanski, Elena V. Babenko, Tatyana L. Gindina, Elena I. Darskaya, Olga A. Slesarchuk, Sergey N. Bondarenko, Boris V. Afanasyev

Abstract: Clinical efficacy of post-transplantation cyclophosphamide (PTCy) as graft-versus-host disease (GVHD) prophylaxis has been demonstrated in haploidentical and HLA-matched bone marrow but not in unrelated peripheral blood stem cell (PBSC) transplantations. Also, no direct comparisons have been published with current standard of care, combination of antithymocyte globulin (ATG), calcineurin inhibitors, and either methotrexate or mycophenolate mofetil (MMF). Eighty-six adult patients (median age 34 years; range, 1…

expand abstract
Filters

Filter received citations by the textual context, citing paper title, authors, etc.

Citation Types

3
25
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship beta

0
0